Skip to content

NWBO NORTHWEST BIOTHERAPEUTICS INC.

Follow

USD (unknown), issuer CIK 1072379

8 managers (8 13F filers) reported a position in NWBO shares at 2026-06-30, 2,221,544 shares in all. 0 filers opened a position and 0 filers sold out during the quarter.

Managers
8
13F filers
8
New
0
Added
1
Reduced
0
Sold out
0
Shares held by filers
2,221,544

Shares held by filers adds up every 13F filer's report, so a share reported by a parent and by its subsidiary counts twice (H9). Managers counts each filer group once.

13D and 13G filers

No 13D or 13G on this security in the data. Structured 13D/G data starts 2024-12-18.

Insider trades

No Form 4 transaction on this security in the data.

13F holders, Q2 2026

Filers in the available 13F reports with a share position at 2026-06-30, filer groups collapsed to one row (method), largest first. Options and principal amounts are left out. A group row states no % of portfolio, since each member reports its own portfolio: the members' percents are listed under it. A value about 1,000 times or 1/1,000 of the price other filers imply is shown as filed but neither ranks the row nor enters a sum.

HolderSharesValue% of portfolioChangeSource
COMPASS FINANCIAL MANAGEMENT LLC1,215,500$227K0.03%13F-HRTimeline
KELLEHER FINANCIAL ADVISORS800,000$149K0.02%+600,00013F-HRTimeline
VSM Wealth Advisory, LLC80,574$15.1K<0.01%013F-HRTimeline
Opus Capital Group, LLC60,150$11K<0.01%013F-HRTimeline
Ethos Financial Group, LLC39,070$6.33K<0.01%013F-HRTimeline
Williams Jones Wealth Management, LLC.25,000$4.67K<0.01%013F-HRTimeline
Coston, McIsaac & Partners1,000$00%013F-HRTimelineValue filed as zero, left out of ratios.
HANTZ FINANCIAL SERVICES, INC.250$00%013F-HRTimelineValue filed as zero, left out of ratios. The filing omitted confidential holdings, a later amendment may add them.